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Extraction of Epinephrine and Norepinephrine by the Dog Pancreas in Vivo 
Bo Ah&n, Beth E. Dunning, Peter J. Havel, Richard C. Veith, and Gerald J. Taborsky, Jr 
This study determined the fractional extraction of epinephrine and norepinephrine by the in situ dog pancreas. Plasma 
samples for epinephrine measurements were taken simultaneously from the femoral artery and the superior pancreatico- 
duodenal vein. Pancreatic extraction of epinephrine was 73 2 5% when basal arterial epinephrine levels were 380 + 93 
pg/mL. 78 + 4% when arterial levels were 898 & 123 pg/mL (epinephrine infused intravenously at 20 ng/kg/min), and 84 ? 
1% when arterial levels were 2,958 + 414 pg/mL lepinephrine infused intravenously at 80 ng/kg/min) suggesting that the 
process of epinephrine extraction by the pancreas is not saturable over this range. During a similar sampling protocol, 
norepinephrine was infused intravenously at 4 pg/kg/min; pancreatic extraction of norepinephrine was then 85 % 7% 
when arterial norepinephrine levels were 107,000 f 28,000 pg/mL. In separate experiments, lower rates of norepineph- 
rine (12 to 1,200 ng/min) were infused directly into the pancreatic artery and pancreatic norepinephrine extraction was 
calculated; it ranged between 88% and 75%. Because the pancreas produces as well as extracts norepinephrine, a third 
technique was required to determine pancreatic norepinephrine extraction at the lower endogenous levels of norepineph- 
rine; ‘H-norepinephrine was infused intravenously and the arteriovenous difference of ‘H-norepinephrine was measured. 
Fractional extraction of ‘H-norepinephrine was 74 + 4% both in the basal state (arterial norepinephrine level = 202 + 44 
pg/mL) and during systemic, glucopenic, stress induced by 2-deoxy-glucose (arterial norepinephrine level = 836 ‘_ 70 
pg/mL). These data suggest that also the norepinephrine extraction process by the pancreas is not sarurable. Further, 
since the pancreatic extraction of norepinephrine is so avid, these data suggest that measurement of the arteriovenous 
concentration difference of endogenous norepinephrine alone will markedly underestimate local norepinephrine spillover. 
Correcting these measurements for the extraction would, however, provide an index of the endogenous activity of 
pancreatic adrenergic nerves. Finally, this study also determined whether pancreatic catecholamine extraction is altered 
by o-or &adrenoceptor antagonists; phenoxybenzamine was found to reduce the extraction of both epinephrine (P < .OOl ) 
and norepinephrine (P < .05) whereas propranolol did not. Thus, one must consider how changes of pancreatic 
catecholamine extraction might alter the interpretation of experiments using a-adrenoceptor antagonists to study local 
norepinephrine release or catecholamine effects on pancreatic hormone secretion. In summary, (1) at steady state 60% to 
80% of either epinephrine or norepinephrine is extracted in one pass by the dog pancreas, (2) this process of extraction 
appears nonsaturable, and (3) the pancreatic extraction of catecholamines is impaired by the n-adrenoceptor antagonist 
phenoxybenzamine, but not by the /3-adrenoceptor antagonist propranolol. 
@ 1988 by Grune & Stratton, Inc. 
C ATECHOLAMINES are known to influence islet function,‘” yet little is known about their pancreatic 
metabolism. However, a correct interpretation of studies on 
catecholamine effects requires a knowledge on pancreatic 
catecholamine metabolism. For example, knowledge of the 
fractional extraction of epinephrine by the pancreas would 
indicate how well pancreatic venous levels reflect the concen- 
tration of circulating epinephrine to which the islets are 
exposed. Further, determination of the fractional rate of 
norepinephrine extraction would allow a better estimation of 
the endogenous activity of the noradrenergic nerves within 
the pancreas. Finally, if autonomic antagonists affect pan- 
creatic catecholamine extraction, then the interpretation of 
the mechanism of their effects on pancreatic hormone 
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secretion and local adrenergic activity could change signifi- 
cantly. 
From studies in various other tissues it is apparent that 
catecholamine extraction is substantial and occurs by at least 
two different mechanisms: the uptake, mechanism, involving 
adrenergic nerve terminals; and the uptake, mechanism, 
involving extraneuronal cells.” The degree of catecholamine 
extraction seems, however, to vary between tissues*-‘5 as may 
the mechanisms regulating catecholamine extraction, For 
example, in response to &adrenoceptor antagonism, the 
uptake, mechanism is increased in salivary gland slices but 
decreased in heart tissue.‘6-‘8 a-Adrenoceptor antagonists 
also influence catecholamine extraction, and phenoxybenz- 
amine has been reported to block both uptake, and uptake, 
mechanisms in vitro.‘6-‘* Therefore, we studied the dog 
pancreas to determine its fractional extraction rate of epi- 
nephrine and norepinephrine and the effects of autonomic 
antagonists thereon. To determine the rate of epinephrine 
extraction by the pancreas, we measured the arteriovenous 
concentration difference of epinephrine across the pancreas 
in the basal state and during low and high rates of intrave- 
nous epinephrine infusion. Determination of the rate of 
norepinephrine extraction is more complicated because 
adrenergic nerves within the pancreas can release norepi- 
nephrine. Thus, pancreatic norepinephrine extraction was 
determined using rates of intravenous or pancreatic intraar- 
terial norepinephrine infusions that far exceeded the rate of 
pancreatic norepinephrine production. Finally, to calculate 
pancreatic norepinephrine extraction during the basal state, 
Metabolism, Vol 37, No 1 (January), 1988: pp 68-73 
CATECHOLAMINE EXTRACTION BY THE PANCREAS 
‘H-norepinephrine was infused intravenously and the arte- 
riovenous concentration difference of ‘H-norepinephrine was 
measured. 
MATERIALS AND METHODS 
Animals and Surgical Procedures 
Adult dogs of mixed breed, weighing 24 to 36 kg, were used. They 
were fasted for 18 hours before the experiments. The experiments 
were carried out under either pentobarbital or halothane (0.8%)/ 
oxygen or halothane (O.l%)/nitrous oxide (70%)/oxygen (30%) 
anesthesia. A midline laparotomy was performed to gain access to 
the superior pancreaticoduodenal vein (SPDV). Blood was routed 
from SPDV via a silastic catheter through an electromagnetic 
flowmeter, past a sampling port, and then into the portal vein. The 
circuit allowed blood flow to be measured continuously and SPDV 
blood to be sampled intermittently. In addition, the femoral artery 
and vein were cannulated for blood sampling and for intravenous 
infusions, respectively. In one experimental series, the superior 
pancreatic artery was isolated and a 22-gauge teflon cannula was 
inserted. The catheter, which did not affect the pancreatic blood 
Row, was then connected to an infusion pump delivering a saline 
infusion (0.9 mL/min). All experiments were performed one hour 
after these surgical procedures. 
Experimental Protocols 
Five different experimental series were performed: 
1. In the first experimental series, the pancreatic extraction of 
epinephrine was studied. Epinephrine (Park-Davis, Morris Plains, 
NJ) was infused intravenously at 20 ng/kg/min or 80 ng/kg/min 
for 40 minutes. 
2. In the second experimental series, the influences of adrenergic 
blockade on the pancreatic fractional extraction rate of epinephrine 
were studied. Dogs were, therefore, treated with the or-adrenoceptor 
antagonist phenoxybenzamine (SK & F Laboratories Ltd. Welwyn 
Garden City, Hertfordshire, England), which was infused into the 
pancreatic artery at 100 hg/min or the P-adrenoceptor antagonist 
propranolol (ICI Ltd. Macclesfield, England), which was infused 
into the pancreatic artery at 2.4 pg/min. 
3. In the third experimental series, the pancreatic extraction of 
norepinephrine was studied. Norepinephrine bitartrate (Breon 
Laboratories Inc. New York) was infused into the pancreatic artery 
at three different doses (12, 120, and 1,200 ng/min) at a volume rate 
of 0.9 mL/min. 
4. In the fourth experimental series, the influences of o(- and 
p-adrenoceptor blockade on the pancreatic extraction of norepineph- 
rine were studied. Norepinephrine bitartrate was infused intrave- 
nously (1 or 4 pg/kg/min) alone or together with phenoxybenz- 
amine and/or propranolol. Phenoxybenzamine was given as an 
intravenous injection of 2.5 mg/kg followed by infusion of 50 
pg/kg/min, and propranolol was given as an intravenous injection of 
300 kg/kg followed by an infusion of 5 Ng/kg/min. The infusions of 
adrenoceptor blockers were started 15 minutes before the norepi- 
nephrine infusion and continued during it. 
5. In the fifth experimental series, the pancreatic fractional 
extraction rate of norepinephrine at low circulating levels of norepi- 
nephrine was studied. ‘H-Norepinephrine (specific activity 47.7 
Ci/mmol, New England Nuclear) was therefore injected intrave- 
nously at the dose of 30 &i followed by an intravenous infusion at 
1.2 rCi/min. After 45 min of infusion, 2-deoxy-glucose (Sigma 
Chemical Co, St Louis) was injected intravenously at 600 mg/kg 
followed by infusion at 13.56 rg/kg/min. The infusion of ‘H- 
norepinephrine continued throughout. 
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Assays and Data Analysis 
Blood was taken in tubes containing EGTA and glutathione, 
placed on ice, and centrifuged at 4°C after the end of the experi- 
ments. Plasma was separated and frozen at -20°C until assay. 
Epinephrine and norepinephrine were measured using a single- 
isotope radioenzymatic assay.” In the experimental series where the 
catecholamines were infused intravenously, the pancreatic extrac- 
tion of epinephrine and norepinephrine was calculated by dividing 
the pancreatic arteriovenous plasma concentration differences by 
the arterial plasma levels. In the experimental series employing 
pancreatic arterial infusions of norepinephrine, the amount of arte- 
rially infused norepinephrine escaping pancreatic extraction was 
calculated by multiplying the pancreatic venous level of norepineph- 
rine by the plasma flow. Since the rate of arterial infusion of 
norepinephrine was known, the extraction of norepinephrine was 
calculated by subtracting the difference between the output before 
and during norepinephrine infusion from the infused rate of norepi- 
nephrine divided by the rate infused. In the experimental series with 
intravenous infusion of ‘H-norepinephrine, intact ‘H-norepinephrine 
was separated from its metabolites in plasma using an alumina 
extraction procedure. Thereafter, the concentration of plasma ‘H- 
norepinephrine was determined by liquid scintillation counting of 
radiolabeled norepinephrine. The pancreatic fractional extraction 
rate was calculated by dividing the pancreatic arteriovenous differ- 
ences of radioactivity by the arterial level. 
Statistics 
The data is reported as mean *SEM. Statistical comparisons of 
means between groups were made with Student’s nonpaired r-test 
and within a group with Student’s paired t-test. For calculating 
correlations between arteriovenous concentration differences and 
arterial levels, linear regression analysis was performed. 
RESULTS 
Pancreatic Extraction of Epinephrine 
The pancreatic extraction of epinephrine was calculated in 
the basal state and during the intravenous infusion of 
epinephrine at 2 different doses (n = 4). Before the infusions, 
the arterial levels of epinephrine were 380 k 93 pg/mL; 
pancreatic venous levels of epinephrine were 88 t 9 pg/mL 
(Fig IA). 73 +- 5% of arterial epinephrine was extracted by 
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Fig 1. Arterial and pancreatic venous levels of epinephrine in 
dogs in the basal state (A) In = 4). and during intravenous infusion 
of epinephrine at 20 ng/kg/min (B) (II = 4) or 80 ng/kg/min (C) 
(n = 4). Mean *SEM is given. Note different scales on the Y-axis. 
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the pancreas in the basal state. During infusion of epineph- 
rine at a dose of 20 ng/kg/min, arterial epinephrine levels 
increased to 896 + 133 pg/mL and pancreatic venous levels 
increased to 193 f 22 pg/mL (Fig 1 B). The mean extraction 
rate in the pancreas was unchanged at 76 + 4%. During 
infusion of epinephrine at a dose of 80 ng/kg/min, arterial 
epinephrine levels increased to 2,956 + 414 pg/mL. Pan- 
creatic venous levels of epinephrine were 461 + 84 pg/mL 
(Fig 1C). The degree of pancreatic extraction of epinephrine 
during this high dose infusion of epinephrine was 84 + 1%. 
Figure 2 shows the relationship between arterial epineph- 
rine level and the arterio-venous concentration difference of 
epinephrine across the pancreas. The close correlation 
(r = t-.998, P < .OOl) over the wide range of arterial epi- 
nephrine levels suggests an unsaturable extraction process. 
Influence of (Y and @-Adrenoceptor Antagonists on the 
Pancreatic Extraction of Epinephrine 
at-Adrenoceptor Antagonist: Phenoxybenzamine. The 
cr-adrenoceptor antagonist phenoxybenzamine was infused 
directly into the pancreatic artery at 100 hg/min (n = 19) 
(Fig 3A). Before the infusion, femoral arterial levels of 
epinephrine were 267 + 56 pg/mL and pancreatic venous 
epinephrine concentrations were 90 + 14 pg/mL. The pan- 
creatic extraction of epinephrine in these dogs was 58 + 5%. 
After 20 minutes of phenoxybenzamine infusion, pancreatic 
venous levels of epinephrine had increased to 188 + 32 
pg/mL, ie, by 98 k 21 pg/mL (P < .OOl), but the arterial 
levels of epinephrine did not change significantly, being 305 
+ 70 pg/mL. The pancreatic extraction of epinephrine 
during infusion of phenoxybenzamine was therefore 
decreased to 23 k 4% (P < .OOl). 
/3-Adrenoceptor Antagonist: Propranolol. The /3-adre- 
noceptor antagonist propranolol was infused into the pan- 
creatic artery at 2.4 rg/min (n = 10) (Fig 3B). Before the 
infusion, arterial levels of epinephrine were 358 f 90 pg/mL, 
pancreatic venous levels were 104 it 18 pg/mL, and pan- 
creatic extraction of epinephrine was 67 * 4%. After 20 
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Fig 2. Correlation between the arterial plasma epinephrine 
levels and the arteriovenous concentration gradient of epineph- 
rine across the dog pancreas in the basal state and during 
intravenous infusion of epinephrine at 20 ng/kg/min or BO ng/ 
kglmin (n = 4). 
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Fig 3. Fractional extraction of epinephrine in the dog pan- 
creas before and during pancreatic arterial infusion of phenoxy- 
benzamine (A) (n - 19) or propranolol (B) in = 10). Mean + SEM is 
given. P indicates the significant levels. 
minutes of pancreatic propranolol infusion, the arterial epi- 
nephrine levels were 326 f 87 pg/mL, the pancreatic venous 
levels were 78 t 18 pg/mL, and the pancreatic extraction of 
epinephrine was 74 + 3%. This value was not significantly 
different from before propranolol infusion. 
Pancreatic Extraction of Norepinephrine 
Norepinephrine was infused into the pancreatic artery at 
three different rates (Fig 4). During a ten-minute infusion of 
norepinephrine at the low dose of 12 ng/min (n = 6), pan- 
creatic output of norepinephrine increased by only 3.3 + 0.6 
ng/min. Thus, of the 12 ng/min infused, 8.7 ng/min was 
extracted by the pancreas. The exact fractional extraction 
rate was 75 + 7%. During pancreatic infusion of norepineph- 
rine at 120 ng/min (n = 6) the pancreatic output of norepi- 
nephrine increased by only 38 + 17 ng/min. The pancreatic 
extraction of norepinephrine was again 75 + 9%. During 
12 120 1200 
Norepinephrine infusion rate ( ng/min) 
Fig 4. Fractional extraction of norepinephrine in the dog 
pancreas during infusion into the pancreatic artery of norepineph- 
rine at either 12 ng/min (II = 6). 120 ng/min (n = 6). or 1,200 
ng/min In = 6). Mean *SEM is given. 
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infusion of norepinephrine at 1,200 ng/min (n = 6) pan- 
creatic output of norepinephrine increased by 407 + 76 
ng/min. The pancreatic extraction of the infused norepi- 
nephrine was 66 + 7%, not significantly different from the 
extraction rates at the 2 lower doses of norepinephrine 
infusion. 
Influence of a- and /l-Adrenoceptor Antagonists on the 
Pancreatic Extraction of Norepinephrine 
Infusion of norepinephrine intravenously at 4 pg/kg/min 
(n = 8) increased the arterial levels of norepinephrine from 
0.12 + 0.03 ng/ml to 107 f 28 ng/mL and increased the 
pancreatic venous levels of norepinephrine from 0.08 5 0.02 
ng/mL to 42 i 12 ng/mL after ten minutes of infusion (Fig 
5). The pancreatic extraction of norepinephrine at these 
elevated norepinephrine levels was 65 + 7%. When the 
/I-adrenoceptor antagonist propranolol was infused intrave- 
nously from 15 minutes before an intravenous norepineph- 
rine infusion for 60 minutes (n = 4), the pancreatic extrac- 
tion rate of norepinephrine was 72 2 7%. This value did not 
differ significantly from that in the previous experiments 
without propranolol. Thereafter, the a-adrenoceptor antago- 
nist phenoxybenzamine was added to the infusion for another 
60 minutes, (n = 4), the fractional extraction rate for norepi- 
nephrine decreased to 58 t 2% (P < .05). 
Pancreatic Extraction Rate at Endogenous 
Norepinephrine Levels 
To determine the extraction of norepinephrine when the 
pancreas is exposed to baseline norepinephrine levels, ‘H- 
norepinephrine was infused for 45 minutes (n = 6) in the 
basal state. Arterial levels of norepinephrine were 253 c 41 
pg/mL and pancreatic venous norepinephrine levels were 
202 2 44 pg/mL. The baseline extraction rate of norepineph- 
P n.s. co.05 
0 Contrds m Propmnolol 
m Propranolol+ Phenoxybenzamine 
Fig 5. Fractional extraction of norepinephrine in the dog 
pancreas during intravenous infusion of norepinephrine (4 gg/ 
kglminl (controls. n = 8). or during intravenous infusion of norepi- 
nephrine (1 pglkglmin) after pretreatment with propranolol 
(n = 8) or propranolol together with phenoxybenzamine (n = 8). 
Mean + SEM is given. 
rine was calculated from the arteriovenous difference of 
alumina-extracted “H-norepinephrine and found to be 73 + 
3%. Intravenous injection of 2-deoxy-glucose during the 
‘H-norepinephrine infusion increased arterial norepineph- 
rine levels to 636 k 70 pg/mL and increased pancreatic 
venous levels of norepinephrine to 56 1 + 112 pg/mL, but did 
not change the fractional extraction rate of ‘H-norepineph- 
rine (73 * 4%). 
DISCUSSION 
The present study used measurements of the arteriovenous 
concentration difference to demonstrate that in vivo 60% to 
80% of arterial epinephrine is extracted by the dog pancreas. 
This rate of fractional extraction is surprisingly high consid- 
ering those reported for other tissues.*-‘* Such avid extraction 
implies that measurements of pancreatic venous epinephrine 
levels would markedly underestimate the concentration of 
circulating epinephrine to which the pancreatic islets are 
exposed. The rate of epinephrine extraction did not decrease 
even when the arterial epinephrine concentration was 
increased to levels seen during severe stress. These data 
imply that the epinephrine extraction process in the pancreas 
is not saturable over most of the physiologic range. 
Pancreatic extraction of endogenous norepinephrine can 
not be calculated solely from measurements of the arteriove- 
nous norepinephrine concentration difference because the 
pancreatic venous norepinephrine level reflects not only that 
part of arterial norepinephrine that escapes pancreatic 
extraction but also the spillover of locally released norepi- 
nephrine. Thus, the pancreatic extraction of endogenous 
norepinephrine was estimated by the arteriovenous differ- 
ence of infused ‘H-norepinephrine. It was found that over 
70% of the ‘H-norepinephrine was extracted both in the 
basal state and when endogenous levels of circulating norepi- 
nephrine are increased during neuroglucopenic stress. This 
high fractional extraction contrasts with the arteriovenous 
concentration difference of unlabeled norepinephrine in the 
basal state of 253 v 202 pg/mL and during glucopenic stress 
of 636 v 561 pg/mL. Thus, these data confirm that the 
arteriovenous concentration difference of endogenous nor- 
epinephrine markedly underestimates the actual pancreatic 
extraction of the norepinephrine that circulates in systemic 
plasma. 
The high rate of arterial norepinephrine extraction by the 
pancreas also implies that arteriovenous concentration dif- 
ference of unlabeled norepinephrine markedly underesti- 
mates the degree of activation of pancreatic adrenergic 
nerves because only a small percentage of arterial norepi- 
nephrine actually contributes to the level of norepinephrine 
measured in the pancreatic venous effluent. Knowledge of 
the fractional extraction of arterial norepinephrine by the 
pancreas, however, allows the appropriate correction of the 
arteriovenous concentration difference and, therefore, a 
more accurate estimation of pancreatic noradrenergic activi- 
ty. 
Recognition that the pancreas produces as well as extracts 
norepinephrine indicates that the arteriovenous concentra- 
tion difference technique can be used to estimate pancreatic 
norepinephrine extraction only when the arterial norepineph- 
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rine level is increased to a point that renders pancreatic 
norepinephrine production negligible by comparison. In the 
present study, we increased arterial norepinephrine levels 
into this range by intra-arterial and by intravenous infusion 
of exogenous norepinephrine. Despite the presence of 
extremely high arterial norepinephrine levels in some of 
these experiments, the fractional extraction of arterial nor- 
epinephrine by the pancreas remained between 60% to 80%. 
These data show that the pancreatic extraction process for 
physiologic levels of circulating arterial norepinephrine is not 
saturable, and they further imply that the uptake processes 
responsible for the extraction of the presumably high synap- 
tic levels of locally released norepinephrine probably also do 
not saturate. 
The amount of catecholamines extracted by the pancreas 
has not been reported before, to our knowledge. Studies in 
other tissues or of whole body extraction have been reported, 
however, and they show a variable extraction rate, which is 
dependent both on the tissue studied and on the experimental 
conditions. For example, in man, the whole body fractional 
extraction rate for norepinephrine was calculated to be 45%.* 
In human forearm’ and in human lung,” rates of 40% and 
25%, were calculated, respectively. In smooth muscle, the 
calculated rate of extraction of neuronally released norepi- 
nephrine was 50%,12 and in dog tracheal tissue, dog saphe- 
nous venous tissue and in dog pulmonary arterial endothe- 
lium, the norepinephrine extraction was calculated as 70% to 
75%.“-‘5 The fractional extraction of epinephrine in human 
forearm was reported to depend on the prevailing epineph- 
rine levels and varied between 26% and 5 1% with the higher 
extraction values seen at high epinephrine levels.” In our 
study, the extraction rate was between 60-80% with the 
highest rate at the highest arterial level of epinephrine tested. 
Thus, our findings suggest that the pancreas has one of the 
higher fractional extraction rates. 
Catecholamine extraction presumably involves neural and 
extraneural uptake, denoted uptake, and uptake,, respec- 
tively. While in earlier studies /I-adrenoceptor antagonists 
were reported to inhibit uptakeI or whole body clearance of 
epinephrine2’ or norepinephrine,2’-23 we found that proprano- 
101 had no effect on the pancreatic extraction of catechol- 
amines. This suggests either that pancreatic extraction is 
mediated only by uptake, or that the more recent interpreta- 
tion of P-blocking studies is correct, namely, that propranolol 
decreases catecholamine clearance by reducing cardiac out- 
put rather than by blockade of uptake per se.9 We also found 
that phenoxybenzamine reduced pancreatic extraction of 
catecholamines. However, this study does not allow distinc- 
tion between uptake, and uptake, because previous studies 
indicate that a-adrenoceptor antagonists can inhibit both 
mechanisms.‘6“8 Whatever the mechanism, synaptic levels of 
norepinephrine would probably be increased in the presence 
of phenoxybenzamine. Thus, the effects of rr-adrenoceptor 
antagonists on pancreatic hormone secretion could. result not 
only from blockade of islet cY-adrenoceptors but also from 
increased local concentrations or norepinephrine. Moreover, 
findings of increased venous norepinephrine levels in pres- 
ence of cy-adrenoceptor antagonists, which have previously 
been ascribed solely to potentiation of neuronal norepineph- 
rine release via blocking presynaptic cy,-adrenoceptors (com- 
pare references l-3,24) may reflect, in addition, blockade of 
extraction. 
It might be argued that changes in blood flow during the 
infusion performed in the study would explain the failure of 
saturation of the catecholamine extraction process. However, 
it is highly unlikely that blood flow is a major determinant of 
catecholamine extraction. Of the 5 different experimental 
protocols used in the present study, pancreatic venous blood 
flow was not significantly altered in protocols no. 1 and no. 2, 
presumably because the systemic effect of the catechol- 
amines on blood pressure counterbalances the presumed 
vasoconstrictor effect on the pancreas. In protocol no. 3, the 
intrapancreatic infusions of norepinephrine, there was a 
progressive decrease of blood flow in response to the graded 
infusions of norepinephrine. For example, when norepineph- 
rine was infused intraarterially at 12 ng/min, pancreatic 
venous blood flow decreased by 1.0 + 0.6 mL/min, at 120 
ng/min by 1.5 k 0.2 ml/mitt, and at 1,200 ng/min by 3.7 + 
0.7 mL/min. It is unlikely that this progressive decrease in 
pancreatic venous blood flow by itself produced a higher 
fractional extraction of norepinephrine and therefore offset 
an effect of high concentrations of norepinephrine to saturate 
the extraction mechanisms, since in protocol no. 4, when 
norepinephrine was given intravenously at very high rates, 
there was no change in pancreatic blood flow and the 
pancreatic extraction of norepinephrine was 65 r 7% v 66 2 
7% seen during the highest rate of arterial norepinephrine 
infusion which had produced a large decrease of pancreatic 
blood flow. Further, in protocol no. 5, injection of 2-deoxy- 
glucose did produce a significant increase of pancreatic blood 
flow of 2 mL/min but no change in norepinephrine extrac- 
tion. 
In summary, this study has shown (1) that in vivo 60% to 
80% of arterial epinephrine or norepinephrine is extracted by 
the dog pancreas during one passage, (2) that this extraction 
process appears non-saturable, and (3) that the extraction of 
epinephrine or norepinephrine is not affected by the fl- 
adrenoceptor antagonist propranolol, but is impaired by the 
a-adrenoceptor antagonist phenoxybenzamine. 
We make the following conclusions: (1) pancreatic venous 
levels of epinephrine will markedly underestimate the circu- 
lating epinephrine concentrations seen by the islets, (2) 
arteriovenous concentration differences of endogenous nore- 
pinephrine across the pancreas will markedly underestimate 
both the pancreatic extraction and spillover of norepineph- 
rine, (3) knowledge of percentage of norepinephrine 
extracted by the pancreas allows one to determine the 
activity of the adrenergic nerves within the pancreas, and (4) 
the effects of a-adrenoceptor blockade on islet hormone 
secretion and pancreatic venous norepinephrine levels are 
due, in part, to reduction of pancreatic norepinephrine 
extraction. 
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